David B. Jack, MD


  • English

Academic Information

  • Departments: Family & Preventive Medicine - Adjunct Instructor
  • Divisions: Family Medicine

Academic Office Information

  • 801-576-8855
  • 9829 South 1300 East, Room: #101
    Sandy, UT 84094

Selected Publications

Journal Article

  1. Rajaraman V, Jack D, Adamovich SV, Hening W, Sage J, Poizner H (2000 Feb). A novel quantitative method for 3D measurement of Parkinsonian tremor. Clin Neurophysiol, 111(2), 338-43.
  2. Jack D (1999 Oct 23). The fine art of medicine. Lancet, 354(9188), 1479-80.
  3. Jack D (1998 Oct). Confessions of a journal junkie. Lancet, 352 Suppl 2, SII23-4.
  4. Jack D (1998 Jan 31). The name of the dose. Lancet, 351(9099), 380.
  5. Jack D (1997 Sep 13). Hot shots inside the body. Lancet, 350(9080), 790.
  6. Jack DB (1997 Aug 9). One hundred years of aspirin. Lancet, 350(9075), 437-9.
  7. Jack D, Bidwell J, Turner M, Wood N (1997). Simultaneous genotyping for all three known structural mutations in the human mannose-binding lectin gene. Hum Mutat, 9(1), 41-6.
  8. Matthew B, Jack D (1996 May). "Lien on me"--veterinary liens for accounts receivable. Can Vet J, 37(5), 312-4.
  9. Bohannon NJ, Jack DB (1996 Mar). Type II diabetes: tips for managing your older patients. Geriatrics, 51(3), 28-35.
  10. Jack DB (1995 Oct). Senate FDA reform bill--good news for the pharmaceutical industry? Mol Med Today, 1(7), 300.
  11. Johnston B, Scott N, Li Wan Po A, Jack DB (1995 Oct). Psychometric profiling of the elderly using the Cambridge Cognitive Examination. Ann Pharmacother, 29(10), 982-7.
  12. Quarino L, Samples M, San Pietro D, Shaler R, Orta A, Jack D (1995 Jul-Sep). Haptoglobin typing of bloodstains using horizontal discontinuous polyacrylamide gel electrophoresis. Sci Justice, 35(3), 213-6.
  13. Jack DB (1995 Jun). Keep taking the tomatoes--the exciting world of nutraceuticals. Mol Med Today, 1(3), 118-21.
  14. Jack D, Matthew B (1994 Jun). Management of accounts receivable, 2. Can Vet J, 35(6), 391-4.
  15. Jack D, Matthew B (1994 May). Management of accounts receivable, 1. Can Vet J, 35(5), 307-12.
  16. Jack DB, Soppitt AJ (1991 Dec 21-28). Give a drug a bad name. BMJ, 303(6817), 1606-8.
  17. Ball DI, Brittain RT, Coleman RA, Denyer LH, Jack D, Johnson M, Lunts LH, Nials AT, Sheldrick KE, Skidmore IF (1991 Nov). Salmeterol, a novel, long-acting beta 2-adrenoceptor agonist: characterization of pharmacological activity in vitro and in vivo. Br J Pharmacol, 104(3), 665-71.
  18. Chellingsworth MC, Laugher S, Akhlaghi S, Jack DB, Kendall MJ (1988 Dec). The effects of ranitidine and cimetidine on the pharmacokinetics and pharmacodynamics of metoprolol. Aliment Pharmacol Ther, 2(6), 521-7.
  19. Jack DB, Hawker JL, Rooney L, Beerahee M, Lobo J, Patel P (1988 Oct 28). Measurement of the distribution coefficients of several classes of drug using reversed-phase thin-layer chromatography. J Chromatogr, 452, 257-64.
  20. Jack D (1988 Jul 2). Pharmacological control of gastric acid secretion. S Afr Med J, 74 Suppl, 8-10.
  21. Jack DB, Mason NP (1987 Dec). The pharmaceutical industry in the U.S.S.R. J Clin Pharm Ther, 12(6), 401-7.
  22. Hall PE, Smith SR, Jack DB, Kendall MJ (1987 Apr). The influence of beta-adrenoceptor blockade on the lipolytic response to exercise. J Clin Pharm Ther, 12(2), 101-6.
  23. Gregg MR, Jack DB, Smith SR, Kendall MJ (1987 Apr). The pharmacokinetics of oxprenolol following oral and rectal dosing--a comparison of delivery systems and routes of administration. J Clin Pharm Ther, 12(2), 91-9.
  24. Smith SR, Kendall MJ, Lobo J, Beerahee A, Jack DB, Wilkins MR (1987 Mar). Ranitidine and cimetidine; drug interactions with single dose and steady-state nifedipine administration. Br J Clin Pharmacol, 23(3), 311-5.
  25. Jack DB, Gortel ZW, Kreuzer HJ (1987 Jan 15). Fokker-Planck equation for physisorption kinetics: General formulation for isothermal desorption. PHYSICAL REVIEW. B. CONDENSED MATTER, 35(2), 468-477.
  26. Beerahee M, Wilkins MR, Jack DB, Beevers DG, Kendall MJ (1987). Twelve hour (trough) plasma nifedipine concentrations during chronic treatment with nifedipine retard. Eur J Clin Pharmacol, 32(4), 347-9.
  27. Lobo J, Jack DB, Kendall MJ (1987). Inter- and intra-subject variability of nitrendipine and the effects of food. Eur J Clin Pharmacol, 32(4), 357-60.
  28. Smith SR, Wilkins MR, Jack DB, Kendall MJ, Laugher S (1987). Pharmacokinetic interactions between felodipine and metoprolol. Eur J Clin Pharmacol, 31(5), 575-8.
  29. Davis RS, Jack DB (1986 Jan-Feb). A surgical cut into computers. MD Comput, 3(1), 21-8.
  30. Lobo J, Jack DB, Kendall MJ (1986). The intra- and inter-subject variability of nifedipine pharmacokinetics in young volunteers. Eur J Clin Pharmacol, 30(1), 57-60.
  31. Clarke AF, Jack DB, Kendall MJ, Smith SR (1986 Jan-Feb). The pharmacokinetics of oral and intravenous prenalterol in young, healthy volunteers. Biopharm Drug Dispos, 7(1), 47-52.
  32. Brittain RT, Boutal L, Carter MC, Coleman RA, Collington EW, Geisow HP, Hallett P, Hornby EJ, Humphrey PP, Jack D, et al (1985 Dec). AH23848: a thromboxane receptor-blocking drug that can clarify the pathophysiologic role of thromboxane A2. Circulation, 72(6), 1208-18.
  33. Brittain RT, Jack D, Reeves JJ, Stables R (1985 Aug). Pharmacological basis for the induction of gastric carcinoid tumours in the rat by loxtidine, an insurmountable histamine H2-receptor blocking drug. Br J Pharmacol, 85(4), 843-7.
  34. Zaman R, Jack DB, Wilkins MR, Kendall MJ (1985 Apr-Jun). Lack of effect of liver disease on the pharmacokinetics of acebutolol and diacetolol: a single dose study. Biopharm Drug Dispos, 6(2), 131-7.
  35. Jack DB, Kreuzer HJ (1985 Feb 15). Kramer's equation for physisorption. PHYSICAL REVIEW. B. CONDENSED MATTER, 31(4), 2514-2516.
  36. Woods KL, Jack DB, Kendall MJ, Halsey A, ODonnell ML, Warrington SJ, John VA (1985). A multiple dose comparative study of the pharmacodynamic and pharmacokinetic behaviour of polymer-matrix and Oros dosage forms of oxprenolol in healthy volunteers. Br J Clin Pharmacol, 19 Suppl 2, 177S-184S.
  37. Jack DB, Kendall MJ, Laugher SJ, Smith SR (1985). Reproducibility of oxprenolol plasma concentrations in young female volunteers following oral administration of an oxprenolol Oros dosage form. Br J Clin Pharmacol, 19 Suppl 2, 185S-190S.
  38. Wilkins MR, Woods KL, Jack DB, Kendall MJ, Laugher SJ (1985). Separate and combined effects of nadolol and nifedipine on the cardiac response to exercise. Eur J Clin Pharmacol, 28(2), 113-7.
  39. Kendall MJ, Jack DB, Laugher SJ, Lobo J, Rolf Smith S (1984 Sep). Lack of a pharmacokinetic interaction between nifedipine and the beta-adrenoceptor blockers metoprolol and atenolol. Br J Clin Pharmacol, 18(3), 331-5.
  40. Lagerstrom PO, Carlebom P, Clarke AF, Jack DB (1984 Apr 13). Determination of prenalterol in plasma and urine by liquid chromatography with electrochemical detection. J Chromatogr, 307(1), 230-4.
  41. Gregg MR, Jack DB (1984 Jan 13). Determination of timolol in plasma and breast milk using high-performance liquid chromatography with electrochemical detection. J Chromatogr, 305(1), 244-9.
  42. Kendall MJ, Jack DB, Quarterman CP, Smith SR, Zaman R (1984). Beta-adrenoceptor blocker pharmacokinetics and the oral contraceptive pill. Br J Clin Pharmacol, 17 Suppl 1, 87S-89S.
  43. Zaman R, Wilkins MR, Kendall MJ, Jack DB (1984 Jan-Mar). The effect of food and alcohol on the pharmacokinetics of acebutolol and its metabolite, diacetolol. Biopharm Drug Dispos, 5(1), 91-5.
  44. Jack DB, Wilkins M, Quarterman CP (1983 Aug). Lack of evidence for polymorphism in metoprolol metabolism. Br J Clin Pharmacol, 16(2), 188-90.
  45. Jack D, Poynter D, Spurling NW (1983 Jul-Aug). Beta-adrenoceptor stimulants and mesovarian leiomyomas in the rat. Toxicology, 27(3-4), 315-20.
  46. Jack DB, Wilkins MR, Kendall MJ, Hall PE (1983). Variability of plasma drug concentrations: some observations. Eur J Clin Pharmacol, 25(4), 569-70.
  47. Jack DB (1983). Statistical analysis of polymorphic drug metabolism data using the Rosin Rammler Sperling Weibull distribution. Eur J Clin Pharmacol, 25(4), 443-8.
  48. Kendall MJ, Quarterman CP, Jack DB, Beeley L (1982 Jul). Metoprolol pharmacokinetics and the oral contraceptive pill. Br J Clin Pharmacol, 14(1), 120-2.
  49. Kendall MJ, Jack DB, Woods KL, Laugher SJ, Quarterman CP, John VA (1982 Mar). Comparison of the pharmacodynamic and pharmacokinetic profiles of single and multiple doses of a commercial slow-release metoprolol formulation with a new Oros delivery system. Br J Clin Pharmacol, 13(3), 393-8.
  50. Crook PR, Willis JV, Kendall MJ, Jack DB, Fowler PD (1982). The pharmacokinetics of diclofenac sodium in patients with active rheumatoid disease. Eur J Clin Pharmacol, 21(4), 331-4.
  51. Jack DB, Quarterman CP, Zaman R, Kendall MJ (1982). Variability of beta-blocker pharmacokinetics in young volunteers. Eur J Clin Pharmacol, 23(1), 37-42.
  52. Jack DB, Kendall MJ, Dean S, Laugher SJ, Zaman R, Tenneson ME (1982 Jan-Mar). The effect of hydralazine on the pharmacokinetics of three different beta adrenoceptor antagonists: metoprolol, nadolol, and acebutolol. Biopharm Drug Dispos, 3(1), 47-54.
  53. Roberts DH, Kendall MJ, Jack DB, Welling PG (1981 Jun). Pharmacokinetics of cephradine given intravenously with and without probenecid. Br J Clin Pharmacol, 11(6), 561-4.
  54. Jack DB (1981 Apr). Is there a relationship between the physical properties and cardioselectivity of beta-adrenoceptor antagonists? Br J Clin Pharmacol, 11(4), 402-6.
  55. Quarterman CP, Kendall MJ, Jack DB (1981 Mar). The effect of age on the pharmacokinetics of metoprolol and its metabolites. Br J Clin Pharmacol, 11(3), 287-94.
  56. Willis JV, Kendall MJ, Jack DB (1981 Jan). The influence of food on the absorption of diclofenac after single and multiple oral doses. Eur J Clin Pharmacol, 19(1), 33-7.
  57. Willis JV, Jack DB, Kendall MJ, John VA (1981 Jan). The influence of food on the absorption of diclofenac as determined by the urinary excretion of the unchanged drug and its major metabolites during chronic administration. Eur J Clin Pharmacol, 19(1), 39-44.
  58. Willis JV, Kendall MJ, Jack DB (1980 Nov). A study of the effect of aspirin on the pharmacokinetics of oral and intravenous diclofenac sodium. Eur J Clin Pharmacol, 18(5), 415-8.
  59. Jack DB, Dean S, Kendall MJ, Laugher S (1980 Aug 1). Detection of some antihypertensive drugs and their metabolites in urine by thin-layer chromatography: II. A further five beta blockers and dihydralazine. J Chromatogr, 196(1), 189-92.
  60. Schweizer A, Willis JV, Jack DB, Kendall MJ (1980 Jul 25). Determination of total monohydroxylated metabolites of diclofenac in urine by electron-capture gas-liquid chromatography. J Chromatogr, 195(3), 421-4.
  61. Quarterman CP, Kendall MJ, Jack DB (1980 Jul 11). Determination of metoprolol metabolites in plasma and urine by electron-capture gas--liquid chromatography. J Chromatogr, 183(1), 92-8.
  62. Jack DB, Dean S, Kendall MJ (1980 Jan 4). Detection of some antihypertensive drugs and their metabolites in urine by thin-layer chromatography. Five commonly used beta blockers and hydralazine. J Chromatogr, 187(1), 277-80.
  63. Jack DB (1980). Tuberculosis therapy and enzyme induction in man. Int J Clin Pharmacol Ther Toxicol, 18(8), 361.
  64. Bradshaw J, Brittain RT, Clitherow JW, Daly MJ, Jack D, Price BJ, Stables R (1979 Jul). Ranitidine (AH 19065): a new potent, selective histamine H2-receptor antagonist [proceedings]. Br J Pharmacol, 66(3), 464P.
  65. Brittain RT, Jack D, Tyers MB (1977 Sep). Pharmacological and certain chemical properties of AH 10407, an unusually short-acting, competitive neuromuscular blocking drug, and some related compounds. Br J Pharmacol, 61(1), 47-55.
  66. Jack D (1977 Apr 13). [Development and pharmacology of beclomethasone dipropionate]. Nouv Presse Med, 6(15), 1273-6.
  67. Jack D (1976 Mar 31). [Essential pharmacology of salbutamol, a highly selective beta-2 adrenergic receptor stimulator]. Minerva Med, 67(16), 1070-8.
  68. Jack DB (1976 Spring). H.M.S. Lochinvar, Port Edgar. J R Nav Med Serv, 62(1), 37-40.
  69. Jack DB, Brechbuher S, Degen PH, Zbinden P, Riess W (1975 Dec 10). The determination of hydralazine in plasma by gas-liquid chromatography. J Chromatogr, 115(1), 87-92.
  70. Michot F, Glaus L, Jack DB, Theobald W (1975 Apr 4). [Anticoagulant efficacy of Sintrom and blood concentration of Ludiomil on simultaneous administration of the two preparations]. Med Klin, 70(14), 626-9.
  71. Brunner L, Imhof P, Jack D (1975). Relation between plasma concentrations and cardiovascular effects of oral oxprenolol in man. Eur J Clin Pharmacol, 8(1), 3-9.
  72. Harris DM, Martin LE, Harrison C, Jack D (1974 Sep). The effect of intra-nasal beclomethasone dipropionate on adrenal function. Clin Allergy, 4(3), 291-4.
  73. Jack D (1974 Feb 16). Symposium on allergic lung disease. V. Selective drug treatments for bronchial asthma. Can Med Assoc J, 110(4), 436 passim.
  74. Jack DB, Riess W (1973 Dec). Pharmacokinetics of iodochlorhydroxyquin in man. J Pharm Sci, 62(12), 1929-32.
  75. Harris DM, Martin LE, Harrison C, Jack D (1973 Sep). The effect of oral and inhaled beclomethasone dipropionate on adrenal function. Clin Allergy, 3(3), 243-8.
  76. Bolger L, Brittain RT, Jack D, Jackson MR, Martin LE, Mills J, Poynter D, Tyers MB (1972 Aug 11). Short-lasting, competitive neuromuscular blocking activity in a series of azobis-arylimidazo-(1,2-a)-pyridinium dihalides. Nature, 238(5363), 354-5.
  77. Jack D, Harris D, Tothill A (1972 Mar 11). Resistance to -adrenoceptor stimulants. Br Med J, 1(801), 688-9.
  78. Gladych JM, Hornby R, Hunt JH, Jack D, Boyle JJ, Ferlauto RJ, Haff RF, Kormendy CG, Stanfield FJ, Stewart RC (1972 Mar). Antiviral agents. 5H-as-Triazino(5,6-b) indoles. J Med Chem, 15(3), 277-81.
  79. Jack DB, Stenlake JB, Templeton R (1972 Jan). The metabolism and excretion of guanoxan in man. Xenobiotica, 2(1), 35-43.
  80. Jack DB, Stenlake JB, Templeton R (1971 Dec). Metabolism and excretion of guanoxan in human. J Pharm Pharmacol, 23, 222S-223S.
  81. Jack D (1971 Jun 19). Sniffing syndrome. Br Med J, 2(763), 708-9.
  82. Ankier SI, Brittain RT, Jack D (1971 May). Investigation of central cholinergic mechanisms in the conscious mouse. Br J Pharmacol, 42(1), 127-36.
  83. Jack D (1971 Mar). An introduction to salbutamol and other modern beta-adrenoreceptor stimulants. Postgrad Med J, 47, Suppl:8-11.
  84. Collin DT, Hartley D, Jack D, Lunts LH, Press JC, Ritchie AC, Toon P (1970 Jul). Saligenin analogs of sympathomimetic catecholamines. J Med Chem, 13(4), 674-80.
  85. Gladych JM, Hunt JH, Jack D, Haff RF, Boyle JJ, Stewart RC, Ferlauto RJ (1969 Jan 18). Inhibition of rhinovirus by isatin thiosemicarbazone analogues. Nature, 221(177), 286-7.
  86. Cullum VA, Farmer JB, Jack D, Levy GP (1969 Jan). Salbutamol: a new, selective beta-adrenoceptive receptor stimulant. Br J Pharmacol, 35(1), 141-51.
  87. Hartley D, Jack D, Lunts LH, Ritchie AC (1968 Aug 24). New class of selective stimulants of beta-adrenergic receptors. Nature, 219(156), 861-2.
  88. Brittain RT, Farmer JB, Jack D, Martin LE, Simpson WT (1968 Aug 24). Alpha-[(t-Butylamino)methyl]-4-hydroxy-m-xylene-alpha 1,alpha 3-diol (AH.3365): a selective beta-adrenergic stimulant. Nature, 219(156), 862-3.


  1. Klein N, Jack D (1999 Nov). Immunodeficiency and the gut: clues to the role of the immune system in gastrointestinal disease. [Review]. Ital J Gastroenterol Hepatol, 31(8), 802-6.
  2. Jack D (1997 May). Current drug treatment of asthma. [Review]. J Pharm Pharmacol, 49 Suppl 3, 17-8.
  3. Jack DB (1996 Dec). Drug-resistant bacteria: responding to the infectious disease crisis. [Review]. Mol Med Today, 2(12), 499-502.
  4. Jack D (1991 May). The 1990 Lilly Prize Lecture. A way of looking at agonism and antagonism: lessons from salbutamol, salmeterol and other beta-adrenoceptor agonists. [Review]. Br J Clin Pharmacol, 31(5), 501-14.
  5. Jack D (1990). Safety by design. [Review]. Drug Saf, 5 Suppl 1, 4-23.
  6. Jack D (1989 May). The challenge of drug discovery. [Review]. Drug Des Deliv, 4(3), 167-86.
  7. Jack DB (1986 Apr). Recent advances in pharmaceutical chemistry. The 4-quinolone antibiotics. [Review]. J Clin Hosp Pharm, 11(2), 75-93.
  8. Jack DB (1985 Mar). Factors contributing to variability in drug pharmacokinetics. III. Metabolism. [Review]. J Clin Hosp Pharm, 10(1), 25-43.
  9. Brittain RT, Jack D (1983). Histamine H2-antagonists--past, present and future. [Review]. J Clin Gastroenterol, 5 Suppl 1, 71-9.
  10. Brittain RT, Dean CM, Jack D (1976). Sympathomimetic bronchodilator drugs. [Review]. Pharmacol Ther [B], 2(3), 423-62.
  11. Jack D (1974). Adrenoceptors and bronchial asthma. [Review]. Scand J Respir Dis Suppl, 89, 29-34.
  12. Brittain RT, Jack D, Ritchie AC (1970). Recent beta-adrenoreceptor stimulants. [Review]. Adv Drug Res, 5, 197-253.


  1. Jack DB (1990 Aug). The therapeutic role of gangliosides. J Clin Pharm Ther, 15(4), 233-9.


  1. Jack D (1997 Jul). Asthma guidelines [Letter to the editor]. Thorax, 52(7), 665; discussion 665-6.
  2. Mead R, Jack D, Pembrey M, Tyfield L, Turner M (1997 Jun 7). Mannose-binding lectin alleles in a prospectively recruited UK population. The ALSPAC Study Team. Avon Longitudinal Study of Pregnancy and Childhood [Letter to the editor]. Lancet, 349(9066), 1669-70.
  3. Jack D (1997 May). The interaction between salmeterol and the beta 2-adrenoceptor protein [Letter to the editor]. Trends Pharmacol Sci, 18(5), 149-51.
  4. Jack D (1995 Jul 22). Popular medical information on Internet [Letter to the editor]. Lancet, 346(8969), 250.
  5. Callegaro L, Jack DB, Samson JC (1991 Mar 30). Campylobacter infections, Guillain-Barre syndrome, and parenteral gangliosides [Letter to the editor]. Lancet, 337(8744), 789.
  6. Jack D, Thomas M, Skidmore IF (1985 Nov 9). Ranitidine and paracetamol metabolism [Letter to the editor]. Lancet, 2(8463), 1067.
  7. Jack D, Poynter D, Smith RN (1985 Sep 7). Antisecretory drugs and gastric cancer [Letter to the editor]. Br Med J (Clin Res Ed), 291(6496), 675.
  8. Jack D, Smith RN, Wise PJ (1984 May). Ranitidine and cimetidine [Letter to the editor]. Ann Intern Med, 100(5), 768-9.
  9. Jack DB, Kendall MJ, Wilkins MR (1983 Jul 9). Drug reactions and the poor metaboliser [Letter to the editor]. Lancet, 2(8341), 110.
  10. Jack D, Mitchard M, Smith RN (1983 Jun 25). Influence of ranitidine on plasma metoprolol concentrations [Letter to the editor]. Br Med J (Clin Res Ed), 286(6383), 2064.
  11. Jack D, Smith RN, Richards DA (1982 Dec 4). Histamine H2 antagonists and the heart [Letter to the editor]. Lancet, 2(8310), 1281-2.
  12. Jack D (1982 Sep 25). Cardiac effects of histamine [Letter to the editor]. Lancet, 2(8300), 720-1.
  13. Jack D, Richards DA, Granata F (1982 Jul 31). Side-effects of ranitidine [Letter to the editor]. Lancet, 2(8292), 264-5.
  14. Jack D, Richards DA (1982 Apr 17). Cimetidine and ranitidine [Letter to the editor]. Lancet, 1(8277), 914.
  15. Jack DB, Kendall MJ (1982 Mar 27). Beta-blockers and debrisoquine metaboliser status [Letter to the editor]. Lancet, 1(8274), 741.
  16. Kendall MJ, Jack DB (1982 Mar). Women in new drug trials [Letter to the editor]. Ann Intern Med, 96(3), 376-7.
  17. Zaman R, Jack DB, Kendall MJ (1981 Sep). The penetration of acebutolol and its major metabolite, diacetolol, into human cerebrospinal fluid and saliva [Letter to the editor]. Br J Clin Pharmacol, 12(3), 427-9.
  18. Jack DB, Dean S, Kendall MJ (1980 Aug). Evaluation of simple method to check compliance with antihypertensive drug therapy [Letter to the editor]. Br J Clin Pharmacol, 10(2), 183-5.
  19. Jack DB, Knepil J, McLay WD, Fergie R (1978 Nov 18). Fatal rifampicin-ethambutol overdosage [Letter to the editor]. Lancet, 2(8099), 1107-8.
  20. Poynter D, Harris DM, Jack D (1978 Jan 7). Salbutamol: lack of evidence of tumour induction in man [Letter to the editor]. Br Med J, 1(6104), 46-7.


  1. Jack D (2001 Apr 14). DAFNE--controlling diabetes the German way. Lancet (357(9263), p. 1185).
  2. Jack D (2000 Nov 4). Roche calls for potency guidelines to help HIV drug prescribing. Lancet (356(9241), p. 1581).
  3. Jack D (1999 Oct 23). Berlin biomedical campus unifies laboratory and clinic. Lancet (354(9188), p. 1452).
  4. Jack D (1999 Jun 19). 54-week results on infliximab attract attention at EULAR. European League against Rheumatism. Lancet (353(9170), p. 2132).
  5. Jack D (1998 Sep 5). Combing the oceans for new therapeutic agents. Lancet (352(9130), p. 794).
  6. Jack D (1998 Jul). Do efflux pumps hold the key to better antifungal treatment? Mol Med Today (4(7), p. 275).
  7. Jack D (1998 Apr 11). Waxing hot and cold in the surgical arena. Lancet (351(9109), p. 1110).
  8. Jack D (1998 Jan 10). Sticky situations: surgical adhesions and adhesives. Lancet (351(9096), p. 118).
  9. Jack D (1997 Jun 14). Avoiding stomas with total anorectal reconstruction. Lancet (349(9067), p. 1750).
  10. Jack DB (1997 Feb). Antibodies fight fat cells in humans as well as in animals? Mol Med Today (3(2), p. 49).
  11. Jack D (1997 Jan 25). Artificial lungs on the way--but don't hold your breath. Lancet (349(9047), p. 260).
  12. Jack DB (1996 Oct 26). Robot surgeons: never mind the cost, feel the quality. Lancet (348(9035), p. 1160).
  13. Jack DB (1996 Jul). Herpes simplex virus and Alzheimer's disease. Mol Med Today (2(7), p. 270).
  14. Jack DB (1996 Jul). Bee-glue reveals anti-inflammatory properties plus. Mol Med Today (2(7), p. 271).
  15. Jack DB (1996 Jun 22). Fighting obesity the Franco-British way. Lancet (347(9017), p. 1756).
  16. Jack DB (1996 May 4). Getting ready for the next influenza pandemic. Lancet (347(9010), p. 1252).
  17. Jack DB (1996 Apr). Traditional Chinese medicine yields a kinase inhibitor for use in cancer and HIV. Mol Med Today (2(4), p. 137).
  18. Jack DB (1996 Jan). Spider farming, spider venom and neurexins. Mol Med Today (2(1), p. 1).
  19. Jack DB (1995 Nov). Advances in tissue repair. Mol Med Today (1(8), p. 351).